Company Overview

PRIME exits and American HealthCare Capital are pleased to introduce two behavioral health companies for sale, both owned by the same individual in Colorado and available as a package deal. One company specializes in TMS therapy and the other in Ketamine Infusion Therapy. Established in 2011, the well-established TMS Therapy clinic has treated over 1,700 patients and provided over 70,000 TMS sessions. The ketamine clinic has been in operation since 2014 and has treated approximately 525 patients with Ketamine IV Infusion services for mental health conditions and chronic pain conditions.

Financial Overview

For TMS, 2022 gross revenues were $1,800,858 billed ($1,300,550 collected) with an adjusted EBITDA of 678,527 (52%). For Ketamine, 2022 gross revenues were $235,657 with an adjusted EBITDA of $116,862. Total gross revenues for both businesses in 2022 were $1,536,157 with an adjusted EBITDA of $795,389. In 2023 gross revenues for both businesses were approximately $1,600,000 with an adjusted EBITDA of $709,110.

Staff Overview

The owner is open to staying on for an intermediary period of 6 to 12 months in an advising capacity but ultimately plans to retire from the practice and focus on teaching and writing post acquisition.

Asking Price

The asking price for this opportunity is $2.5 million.